NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Cancer Retreat To Mark International Clinical Trials Day

By Irish Pharmacist - 24th Jun 2022

Pictured at the second annual Cancer Retreat organised by Cancer Trials Ireland to mark International Clinical Trials Day (May 20) were Ms Deirdre Somers, Chair, Cancer Trials Ireland, and Prof Ray McDermott, consultant medical oncologist and Cancer Trials Ireland Clinical Lead. 

The retreat took place in the Royal College of Surgeons, Dublin 2, and saw a number of Irish and international speakers come together to discuss a range of current issues of interest to the cancer clinical trials community, as well as future challenges and opportunities. Latest figures from Cancer Trials Ireland show that there were 364 people enrolled on clinical trials in Ireland in 2021, up from 320 in 2020. The retreat was supported by Pfizer, Roche, AbbVie, MSD, Novartis and Bayer. More information at www. cancertrials.ie. 

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist May 2024

Irish Pharmacist May 2024. Volume 25 | Issue 5 | May 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT